Brief Advice, Nicotine Replacement Therapy Sampling and Active Referral (BANSAR) for Smoking Fathers
Not Applicable
Completed
- Conditions
- Tobacco Use CessationSmoking Cessation
- Interventions
- Behavioral: Very brief adviceBehavioral: Brief AWARD adviceDrug: Nicotine replacement therapy samplingBehavioral: LeafletBehavioral: Active referral
- First Posted Date
- 2018-09-14
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 1053
- Registration Number
- NCT03671707
- Locations
- 🇭🇰
School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong
Use of Diathermy Versus Blunt Dissection in TEP for Inguinal Hernia
Not Applicable
Completed
- Conditions
- SeromaHernia, Inguinal
- Interventions
- Procedure: Blunt dissectionProcedure: Monopolar energy
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 103
- Registration Number
- NCT03665883
- Locations
- 🇨🇳
Department of Surgery, The University of Hong Kong - Shenzhen Hospital, Shenzhen, Guangdong, China
Outcomes of Restoring Untreated and SDF-treated Dentine Caries Lesions in Primary Teeth of Preschool Children
Not Applicable
- Conditions
- Dental Restoration Failure of Marginal Integrity
- Interventions
- Device: application of 38% silver diamine fluoride solutionOther: application of a placebo (tonic water)
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 195
- Registration Number
- NCT03657862
- Locations
- 🇨🇳
The University of Hong Kong, Hong Kong, China
Effectiveness on SDF Solution and PVP-I Combined NaF Varnish in Preventing Root Caries in Elders
Not Applicable
- Conditions
- Root Caries
- Interventions
- Device: SDF solutionDevice: PVP-I solution combined with NaF varnish
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 353
- Registration Number
- NCT03654820
- Locations
- 🇨🇳
The University of Hong Kong, Hong Kong, China
Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors
Phase 2
- Conditions
- EGFR Activating MutationNSCLC Stage IVNSCLC Stage IIIB
- Interventions
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 40
- Registration Number
- NCT03647956
- Locations
- 🇭🇰
Department of Clinical Oncology, Hong Kong, Hong Kong
Exploring the Mental Health of Parents Having Children With Cancer
Completed
- Conditions
- Resilience of Parents Having Children With Cancer
- Interventions
- Other: Exposure_having children with cancer
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2019-05-30
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 181
- Registration Number
- NCT03631485
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
The Hong Kong CML Registry
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2018-08-10
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 200
- Registration Number
- NCT03625583
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia
Phase 2
Recruiting
- Conditions
- Acute Promyelocytic Leukemia
- Interventions
- Drug: Oral arsenic Trioxide, ATRA and ascorbic acid
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT03624270
- Locations
- 🇭🇰
Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hong Kong, N/A = Not Applicable, Hong Kong
SIMPLE Chemotherapy for NK Lymphoma/Leukaemia
Phase 3
- Conditions
- Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin T-cell LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- Interventions
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 68
- Registration Number
- NCT03623087
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 46
- Registration Number
- NCT03622541
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath